Provided herein are tetrazolone FASN inhibitors of the formula (I):
or a pharmaceutically acceptable form thereof; wherein the variables R
A
, R
B
and R
C
are defined herein.
Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections.
The invention relates to a compound of formula (I), wherein R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
The invention relates to a compound of formula (I)
wherein R
1
and R
2
are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.